As we know, the most prestigious example of DRG is MGMT in glioma, which was demonstrated as a prognostic indicator to predict the therapeutic advantage of chemotherapy regimen, for example, nitrosoureas (Esteller et al., 2000) and temozolomide (Hegi et al., 2004). The gene discussed is MGMT; the disease is glioma.